Q-omics provides the consensus-scored MIR605 profile across patient tissues and cancer cell-line models. MIR605 expression is associated with patient survival in 9 of 34 cancer types, with the highest sampling consensus in BLCA. Additionally, MIR605 RNA expression shows 14,341 significant protein co-abundance associations, with the highest sampling consensus in LUAD. Together, these results highlight BLCA, and LUAD as cancer lineages where MIR605 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.